Embody Biosciences

Embody Biosciences (EmbodyBio) is a pioneer in developing bio-digital twin platforms for precision medicine, wellness, and biopharmaceutical research and development. Founded in 2020 and based in Corte Madera, California, the company leverages computational systems physiology and Bayesian machine learning to create holistic models of human physiology. Their platform integrates multi-omic data to provide predictive analytics and individual-patient mechanism of action (MoA) assessments. EmbodyBio's current focus is on brain health and neurodegeneration, with applications in Alzheimer's Disease, Parkinson's Disease, and Multiple Sclerosis. The company maintains an exclusive partnership with Thorne HealthTech for brain health in the wellness space and collaborates with academic institutions to accelerate therapeutic discovery.